The S&P 500 and the Nasdaq dropped from record highs on Tuesday, as Tesla shares were hit by a renewed spat between CEO Elon ...

Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...

Following quite encouraging news from the laboratory on Monday, Amgen (NASDAQ: AMGN) was something of a stock market favorite the following day. Its shares closed the trading session more than 4% ...

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

US Stock futures rise slightly after a weak tech-led start to the second half of 2025, offering signs of investor caution but ...

The Dow Jones Industrial Average is rallying Tuesday afternoon with shares of Amgen and Merck delivering the strongest returns for the blue-chip average.

Investors await progress on trade deals with the return of President Trump's sweeping tariffs just a week away.

Buoyed by positive gains for shares of Amgen and Merck, the Dow Jones Industrial Average is climbing Tuesday morning. Supported by world-class markets data from Dow Jones and FactSet, and partnering ...

"Ligand has been an incredible partner over the past few years, and we look forward to their continued guidance and support ...

Edward Makgotlho is the Area Head of Scientific Affairs, Sub-Saharan Africa at BAT and strongly advocates for evidence-based ...

If you want to know who really controls Neumora Therapeutics, Inc. (NASDAQ:NMRA), then you'll have to look at the makeup of its share registry. We can see that institutions own the lion's share in the ...

The S&P 500 isn’t climbing like it should be, and three major companies are dragging it down hard. Apple, Google’s Alphabet, and Tesla are underperforming ...